GloGlo
Curing and preventing type 1 diabetes
Our mission: eradicate type 1 diabetes. GloGlo is building an AI-native therapeutics company focused on accelerating the discovery of treatments that can prevent, stop, and ultimately cure type 1 diabetes. We are developing AI research agents that continuously analyze scientific literature and biological datasets, generate and challenge hypotheses, design experiments, and run them in a wet lab to learn from experimental results. We are building a tight "in silico <> in vitro/vivo" feedback loop that helps us identify better targets, run experiments more efficiently, and move faster toward therapies for type 1 diabetes.
- Website
- gloglo.com
- City
- San Francisco
- Country
- United States
- YC batch
- Winter 2024
- Team
- 3 people
- Stage
- Early stage
- AI-native
- Yes
- Hiring
- Open roles
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run gloglo.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to GloGlo across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with GloGlo's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
